Comparison of Access to Novel Drugs for Lymphoma and Chronic Lymphocytic Leukemia Between India and the United States

por Sathyanarayanan, Vishwanath, Flowers, Christopher R., Iyer, Swaminathan P.
Publicado 2020

Cryptococcal meningoencephalitis in patients with mantle cell lymphoma on ibrutinib

por Sun, Kai, Kasparian, Saro, Iyer, Swaminathan, Pingali, Sai Ravi
Publicado 2018

Targeting CLL-1 for acute myeloid leukemia therapy

por Ma, Hongbing, Padmanabhan, Iyer Swaminathan, Parmar, Simrit, Gong, Yuping
Publicado 2019

Use of PEG-asparaginase in a case of Hepatosplenic γδ T-cell lymphoma with long-term remission after stem cell transplantation

por Sun, Kai, Sanchez, Cesar Gentille, Pingali, Sai Ravi, Iyer, Swaminathan
Publicado 2018

Complete Response to R-EPOCH in Primary Cardiac Lymphoma

por Anand, Kartik, Pingali, Sai Ravi, Trachtenberg, Barry, Iyer, Swaminathan Padmanabhan
Publicado 2019

Emerging Therapeutic Landscape of Peripheral T-Cell Lymphomas Based on Advances in Biology: Current Status and Future Directions

por Khan, Maliha, Samaniego, Felipe, Hagemeister, Fredrick B., Iyer, Swaminathan P.
Publicado 2021

Use of PEG-asparaginase in monomorphic epitheliotropic intestinal T-cell lymphoma, a disease with diagnostic and therapeutic challenges

por Gentille, Cesar, Qin, Qian, Barbieri, Andreia, Ravi, Pingali Sai, Iyer, Swaminathan
Publicado 2017

Sustained response to erythropoietin for anemia in NK-cell large granular lymphocytosis: A brief case report

por Kwaramba, Tendai, Lewis, Brian, Burks, Bruce, Ruiz, Bernardo, Iyer, Swaminathan P., Safa, Firas
Publicado 2022

P1241: A NOVEL CEREBLON-BINDING MOLECULAR GLUE, SP-3164, SHOWS PRECLINICAL ACTIVITY IN NON-HODGKIN LYMPHOMAS

por Santiesteban, Daniela, Duncan, Aundrietta D., Mirza, Nadeem Q., Horrigan, Stephen, Dewitt, Sheila, Jacques, Vincent, Iyer, Swaminathan P.
Publicado 2023

Recovery of Aging-Related Size Increase of Skin Epithelial Cells: In vivo Mouse and In vitro Human Study

por Sokolov, Igor, Guz, Natali V., Iyer, Swaminathan, Hewitt, Amy, Sokolov, Nina A., Erlichman, Joseph S., Woodworth, Craig D.
Publicado 2015

Mycobacterial infections due to PD-1 and PD-L1 checkpoint inhibitors

por Anand, Kartik, Sahu, Geetanjali, Burns, Ethan, Ensor, Allyne, Ensor, Joe, Pingali, Sai Ravi, Subbiah, Vivek, Iyer, Swaminathan P
Publicado 2020

T-cell lymphoma secondary to checkpoint inhibitor therapy

por Anand, Kartik, Ensor, Joe, Pingali, Sai Ravi, Hwu, Patrick, Duvic, Madeleine, Chiang, Stephen, Miranda, Roberto, Zu, Youli, Iyer, Swaminathan
Publicado 2020

Angioimmunoblastic T-cell lymphoma associated with immune checkpoint inhibitor treatment

por Duke, Taylor C., Nair, Ranjit, Torres-Cabala, Carlos, Amaria, Rodabe N., Keiser, Elizabeth, Miranda, Roberto, Iyer, Swaminathan P., Heberton, Meghan
Publicado 2020

G6PD deficiency and severity of COVID19 pneumonia and acute respiratory distress syndrome: tip of the iceberg?

por Youssef, Jihad G., Zahiruddin, Faisal, Youssef, George, Padmanabhan, Sriram, Ensor, Joe, Pingali, Sai Ravi, Zu, Youli, Sahay, Sandeep, Iyer, Swaminathan P.
Publicado 2021

Highly effective combination of LSD1 (KDM1A) antagonist and pan-histone deacetylase inhibitor against human AML cells

por Fiskus, Warren, Sharma, Sunil, Shah, Bhavin, Portier, Bryce P., Devaraj, Santhana G. T., Liu, Ka, Iyer, Swaminathan P., Bearss, David, Bhalla, Kapil N.
Publicado 2014

HEXIM1 induction is mechanistically involved in mediating anti-AML activity of BET protein bromodomain antagonist

por Devaraj, Santhana G. T., Fiskus, Warren, Shah, Bhavin, Qi, Jun, Sun, Baohua, Iyer, Swaminathan P, Sharma, Sunil, Bradner, James E., Bhalla, Kapil N.
Publicado 2015

P1130: FRONTLINE BRENTUXIMAB VEDOTIN AND CHP (A+CHP) IN PATIENTS WITH PERIPHERAL T-CELL LYMPHOMA WITH LESS THAN 10% CD30 EXPRESSION: INITIAL SAFETY AND EFFICACY RESULTS FROM THE PH...

por Iyer, Swaminathan, Jagadeesh, Deepa, Domingo Domènech, Eva, Benedetti, Fabio, Rodriguez Izquierdo, Antonia, Bouabdallah, Kamal, Vitolo, Umberto, Illidge, Tim, Liu, Jingmin, Knowles, Scott, Horwitz, Steven
Publicado 2023

Pre-clinical efficacy of combined therapy with novel β-catenin antagonist BC2059 and histone deacetylase inhibitor against AML cells

por Fiskus, Warren, Sharma, Sunil, Saha, Saikat, Shah, Bhavin, Devaraj, Santhana G. T., Sun, Baohua, Horrigan, Stephen, Leveque, Christopher, Zu, Youli, Iyer, Swaminathan, Bhalla, Kapil N.
Publicado 2014

SMARCAD1 Phosphorylation and Ubiquitination Are Required for Resection during DNA Double-Strand Break Repair

por Chakraborty, Sharmistha, Pandita, Raj K., Hambarde, Shashank, Mattoo, Abid R., Charaka, Vijaya, Ahmed, Kazi M., Iyer, Swaminathan P., Hunt, Clayton R., Pandita, Tej K.
Publicado 2018

Aggressive primary cutaneous anaplastic large cell lymphoma with massive bilateral upper limb involvement at relapse

por Nguyen, Christopher N., Iyer, Swaminathan P., Miranda, Roberto N., Torres-Cabala, Carlos A., Curry, Jonathan L., Fang, Penny, Thomas, Valencia D., Huen, Auris O.
Publicado 2021